Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis

[1]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[2]  P. Tamboli,et al.  Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray , 2004, Histopathology.

[3]  W. Murphy,et al.  Tumors of the kidney, bladder, and related urinary structures , 2004 .

[4]  C. Langner,et al.  Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors , 2004, Virchows Archiv.

[5]  H. Robenek,et al.  Cholesterol transporter caveolin‐1 transits the lipid bilayer during intracellular cycling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  P. Malfertheiner,et al.  Expression of caveolin-1 in gastrointestinal and extraintestinal cancers , 2003, Journal of Cancer Research and Clinical Oncology.

[7]  M. Morgan,et al.  Caveolin expression in adult renal tumors. , 2003, Urologic oncology.

[8]  J. Cheville,et al.  Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma , 2003, The American journal of surgical pathology.

[9]  M. Glaser,et al.  Caveolin scaffolding region and the membrane binding region of SRC form lateral membrane domains. , 2003, Biochemistry.

[10]  A. Renshaw.  Subclassification of renal cell neoplasms: an update for the practising pathologist. , 2002, Histopathology.

[11]  T. Wheeler,et al.  Cytokeratins 7 and 20 Immunoreactivity in Chromophobe Renal Cell Carcinomas and Renal Oncocytomas , 2002, Modern Pathology.

[12]  H. Levin,et al.  The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. , 2002, Annals of diagnostic pathology.

[13]  M. Mathers,et al.  Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma , 2002, Histopathology.

[14]  P. Chu,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[15]  Barbara J. Reaves,et al.  Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes. , 2002, Molecular biology of the cell.

[16]  Mahul B. Amin,et al.  Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 Cases , 2002, The American journal of surgical pathology.

[17]  C. Fanning,et al.  Can renal oncocytomas be distinguished from renal cell carcinoma on fine‐needle aspiration specimens? , 2001, Cancer.

[18]  L. Weiss,et al.  Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases , 2001, Histopathology.

[19]  A. Scarpa,et al.  Parvalbumin Is Constantly Expressed in Chromophobe Renal Carcinoma , 2001, Modern Pathology.

[20]  L. Weiss,et al.  Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours , 2001, Histopathology.

[21]  A. Gown,et al.  Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. , 2001, Archives of pathology & laboratory medicine.

[22]  Pingsheng Liu,et al.  Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. , 2001, Journal of cell science.

[23]  K. Hunt,et al.  Alveolar soft part sarcoma , 2001, Cancer.

[24]  S. Tickoo,et al.  Ultrastructural Observations on Mitochondria and Microvesicles in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Eosinophilic Variant of Conventional (Clear Cell) Renal Cell Carcinoma , 2000, The American journal of surgical pathology.

[25]  F. Saint,et al.  Utility of Cytokeratin 7 for Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma , 2000, European Urology.

[26]  A. Renshaw,et al.  Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. , 2000, The American journal of surgical pathology.

[27]  E. Jones,et al.  Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. , 1999, American journal of clinical pathology.

[28]  S. Tickoo,et al.  Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. , 1999, The American journal of surgical pathology.

[29]  S. Tickoo,et al.  Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. , 1998, The American journal of surgical pathology.

[30]  M. Toublanc,et al.  Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. , 1997, Archives of pathology & laboratory medicine.

[31]  M. Amin,et al.  Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. , 1997, The American journal of surgical pathology.

[32]  V. Reuter,et al.  Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. , 1997, Ultrastructural pathology.

[33]  P. Russo,et al.  Renal oncocytoma: a clinicopathologic study of 70 cases. , 1997, The American journal of surgical pathology.

[34]  S. Tickoo,et al.  Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. , 1997, The American journal of surgical pathology.

[35]  Lesline P.Gartner,et al.  Color Textbook of Histology , 1997 .

[36]  M. Lisanti,et al.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. , 1996, The Journal of biological chemistry.

[37]  M. Ali,et al.  Chromophobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases. , 1995 .

[38]  S. Bonsib,et al.  Renal chromophobe cell carcinoma: limitations of paraffin-embedded tissue. , 1993, Ultrastructural pathology.

[39]  F. Micali,et al.  Incidentally detected renal cell carcinoma: Role of ultrasonography , 1992, Journal of clinical ultrasound : JCU.

[40]  Richard G. W. Anderson,et al.  Caveolin, a protein component of caveolae membrane coats , 1992, Cell.

[41]  M. Gaffey,et al.  Immunocytochemical characterization of a monoclonal antibody directed against mitochondria reactive in paraffin-embedded sections. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[42]  M J Metzelaar,et al.  CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. , 1991, The Journal of biological chemistry.

[43]  J. Bancroft,et al.  Theory and Practice of Histological Techniques , 1990 .

[44]  S. Bonsib,et al.  Chromophobe Cell Carcinoma: Analysis of Five Cases , 1990, The American journal of surgical pathology.

[45]  S. Störkel,et al.  The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[46]  R. Moll,et al.  Chromophobe cell renal carcinoma and its variants—a report on 32 cases , 1988, The Journal of pathology.

[47]  D. Ruiter,et al.  Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections , 1986, Histopathology.

[48]  A. Kolk,et al.  Biochemical characterization and cellular localization of a formalin‐resistant melanoma‐associated antigen reacting with monoclonal antibody NKI/C‐3 , 1985, International journal of cancer.

[49]  I. Campbell,et al.  Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. , 1984, Journal of clinical pathology.

[50]  E. Beckman,et al.  Renal oncocytoma and its congeners. , 1983, American journal of clinical pathology.

[51]  J. Patard,et al.  Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. , 2004, European urology.

[52]  J. Rosai.  Rosai and Ackerman's Surgical Pathology, Vol. 1 , 2004 .

[53]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[54]  S. Mcphee,et al.  Current Medical Diagnosis & Treatment , 1993 .

[55]  V. Paradis,et al.  [Is it useful to isolate a chromophobe cell variant among carcinomas of the kidney?]. , 1992, Archives d'anatomie et de cytologie pathologiques.

[56]  T. Ekfors,et al.  Alveolar soft part sarcoma. Immunohistochemical evidence for muscle cell differentiation. , 1990, American journal of clinical pathology.

[57]  M. Müller,et al.  Cytoplasmic microvesicles in chromophobe cell renal carcinoma demonstrated by freeze fracture , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[58]  A. A. Palmer,et al.  A COMPARISON OF SOME METHODS FOR IDENTIFYING AMELANOTIC AND OLIGOMELANOTIC MELANOMA METASTASES IN PARAFFIN SECTIONS , 1985, Pathology.

[59]  S. Störkel,et al.  Human chromophobe cell renal carcinoma , 1985, Virchows Archiv. B, Cell pathology including molecular pathology.